tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Abivax completes enrollment in ABTECT trials
The FlyAbivax completes enrollment in ABTECT trials
13h ago
ABVX
Abivax management to meet with BTIG
PremiumThe Fly
Abivax management to meet with BTIG
18h ago
ABVX
Abivax Announces Share and Voting Rights Update
PremiumCompany Announcements
Abivax Announces Share and Voting Rights Update
1M ago
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
PremiumRatings
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
1M ago
ABVX
Abivax Files Key Financial Documents with Regulatory Authorities
PremiumCompany Announcements
Abivax Files Key Financial Documents with Regulatory Authorities
1M ago
Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
PremiumRatingsPromising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
1M ago
ABVX
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
Premium
Ratings
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
1M ago
ABVX
Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
Premium
Ratings
Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
1M ago
ABVX
Abivax SA Reports 2024 Financial Results and Advances Phase 3 Trials
PremiumCompany Announcements
Abivax SA Reports 2024 Financial Results and Advances Phase 3 Trials
1M ago
0RA9 Earnings this Week: How Will it Perform?
PremiumPre-Earnings
0RA9 Earnings this Week: How Will it Perform?
1M ago
Abivax assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Abivax assumed with an Equal Weight at Morgan Stanley
1M ago
ABVX
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
PremiumRatings
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
1M ago
ABVX
Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025
PremiumRatingsAbivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025
1M ago
ABVX
Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment
Premium
Ratings
Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment
1M ago
ABVX
Abivax Announces Share and Voting Rights Update
Premium
Company Announcements
Abivax Announces Share and Voting Rights Update
2M ago
Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
PremiumCompany Announcements
Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
2M ago
Abivax management to meet with Piper Sandler
PremiumThe Fly
Abivax management to meet with Piper Sandler
3M ago
ABVX
Abivax Releases 2025 Financial Communication Schedule
PremiumCompany Announcements
Abivax Releases 2025 Financial Communication Schedule
3M ago
Abivax Discloses Share Capital and Voting Rights Information
PremiumCompany Announcements
Abivax Discloses Share Capital and Voting Rights Information
3M ago
Abivax Presents Key Findings on Obefazimod at ECCO 2025
PremiumCompany AnnouncementsAbivax Presents Key Findings on Obefazimod at ECCO 2025
3M ago
Abivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
Premium
Company Announcements
Abivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
4M ago
Abivax Announces Board Change as Key Director Resigns
Premium
Company Announcements
Abivax Announces Board Change as Key Director Resigns
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >